Education
About Us
Working with TipRanks
Follow Us
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
| Dec 10 | Dec 09 | Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | - | - |
| Operating Income | $ -26.33M | $ -40.44M | $ -49.16M | $ -35.35M | $ -21.23M |
| EBITDA | $ -25.02M | $ -38.97M | $ -47.55M | $ -34.22M | $ -17.02M |
| Net Income | $ -30.05M | $ -45.72M | $ -48.56M | $ -32.78M | $ -23.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 11.64M | $ 52.44M | $ 84.23M | $ 105.14M | $ 69.07M |
| Total Debt | $ 1.57M | $ 20.27M | $ 25.36M | $ 10.81M | $ 13.88M |
| Net Debt | $ -2.76M | $ -23.12M | $ -47.39M | $ -81.81M | $ -39.83M |
| Total Liabilities | $ 3.19M | $ 28.80M | $ 36.59M | $ 16.04M | $ 22.18M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -24.28M | $ -35.51M | $ -33.88M | $ -30.43M | $ -22.66M |
| Operating Cash Flow | $ -24.28M | $ -35.49M | $ -33.49M | $ -24.65M | $ -17.27M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Poniard Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.